These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 26273573)
1. Application of radiation technology in vaccines development. Seo HS Clin Exp Vaccine Res; 2015 Jul; 4(2):145-58. PubMed ID: 26273573 [TBL] [Abstract][Full Text] [Related]
2. Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine. Zuckermann FA; Martin S; Husmann RJ; Brandt J Adv Vet Med; 1999; 41():447-61. PubMed ID: 9890035 [TBL] [Abstract][Full Text] [Related]
3. Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries. Walker RI Vaccine; 2005 May; 23(26):3369-85. PubMed ID: 15837361 [TBL] [Abstract][Full Text] [Related]
4. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal. Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502 [TBL] [Abstract][Full Text] [Related]
6. 30-Year Development of Inactivated Virus Vaccine in China. Shi J; Shen A; Cheng Y; Zhang C; Yang X Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140062 [TBL] [Abstract][Full Text] [Related]
7. Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators. Tandrup Schmidt S; Foged C; Korsholm KS; Rades T; Christensen D Pharmaceutics; 2016 Mar; 8(1):. PubMed ID: 26978390 [TBL] [Abstract][Full Text] [Related]
8. Live attenuated and inactivated viral vaccine formulation and nasal delivery: potential and challenges. Tlaxca JL; Ellis S; Remmele RL Adv Drug Deliv Rev; 2015 Oct; 93():56-78. PubMed ID: 25312673 [TBL] [Abstract][Full Text] [Related]
9. Strategies of constructing recombinant vaccines. Sałamaszyńska-Guz A; Klimuszko D Pol J Vet Sci; 2009; 12(1):133-9. PubMed ID: 19459451 [TBL] [Abstract][Full Text] [Related]
14. Immunization: a key to primary health care. Program for Appropriate Technology in Health PATH Health Technol Dir; 1983 Jan; 3(1):1-6. PubMed ID: 12268557 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of rotavirus vaccines in small animal models. Ciarlet M; Conner ME Methods Mol Med; 2000; 34():147-87. PubMed ID: 21318860 [TBL] [Abstract][Full Text] [Related]
16. Mucosal Vaccine Development Based on Liposome Technology. Bernasconi V; Norling K; Bally M; Höök F; Lycke NY J Immunol Res; 2016; 2016():5482087. PubMed ID: 28127567 [TBL] [Abstract][Full Text] [Related]
17. Vaccine development: From concept to early clinical testing. Cunningham AL; Garçon N; Leo O; Friedland LR; Strugnell R; Laupèze B; Doherty M; Stern P Vaccine; 2016 Dec; 34(52):6655-6664. PubMed ID: 27769596 [TBL] [Abstract][Full Text] [Related]
18. Cancer vaccines: an update with special focus on ganglioside antigens. Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591 [TBL] [Abstract][Full Text] [Related]
19. Development of an Alternative Modified Live Influenza B Virus Vaccine. Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580 [TBL] [Abstract][Full Text] [Related]
20. The Regulatory Evaluation of Vaccines for Human Use. Baylor NW Methods Mol Biol; 2022; 2412():483-501. PubMed ID: 34918264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]